nodes	percent_of_prediction	percent_of_DWPC	metapath
Saxagliptin—Lymphopenia—Riluzole—amyotrophic lateral sclerosis	0.105	0.109	CcSEcCtD
Saxagliptin—Blood creatine phosphokinase increased—Riluzole—amyotrophic lateral sclerosis	0.0777	0.0814	CcSEcCtD
Saxagliptin—Purpura—Riluzole—amyotrophic lateral sclerosis	0.0403	0.0422	CcSEcCtD
Saxagliptin—Face oedema—Riluzole—amyotrophic lateral sclerosis	0.0375	0.0393	CcSEcCtD
Saxagliptin—Gastritis—Riluzole—amyotrophic lateral sclerosis	0.0344	0.036	CcSEcCtD
Saxagliptin—Pancreatitis—Riluzole—amyotrophic lateral sclerosis	0.0329	0.0345	CcSEcCtD
Saxagliptin—Erectile dysfunction—Riluzole—amyotrophic lateral sclerosis	0.0309	0.0324	CcSEcCtD
Saxagliptin—Infestation NOS—Riluzole—amyotrophic lateral sclerosis	0.0299	0.0313	CcSEcCtD
Saxagliptin—Infestation—Riluzole—amyotrophic lateral sclerosis	0.0299	0.0313	CcSEcCtD
Saxagliptin—Urinary tract infection—Riluzole—amyotrophic lateral sclerosis	0.0291	0.0305	CcSEcCtD
Saxagliptin—Sinusitis—Riluzole—amyotrophic lateral sclerosis	0.0281	0.0294	CcSEcCtD
Saxagliptin—Oedema peripheral—Riluzole—amyotrophic lateral sclerosis	0.0265	0.0277	CcSEcCtD
Saxagliptin—Immune system disorder—Riluzole—amyotrophic lateral sclerosis	0.0243	0.0254	CcSEcCtD
Saxagliptin—Malnutrition—Riluzole—amyotrophic lateral sclerosis	0.0234	0.0245	CcSEcCtD
Saxagliptin—Flatulence—Riluzole—amyotrophic lateral sclerosis	0.023	0.0241	CcSEcCtD
Saxagliptin—Angioedema—Riluzole—amyotrophic lateral sclerosis	0.0214	0.0224	CcSEcCtD
Saxagliptin—Myalgia—Riluzole—amyotrophic lateral sclerosis	0.0199	0.0208	CcSEcCtD
Saxagliptin—Arthralgia—Riluzole—amyotrophic lateral sclerosis	0.0199	0.0208	CcSEcCtD
Saxagliptin—Unspecified disorder of skin and subcutaneous tissue—Riluzole—amyotrophic lateral sclerosis	0.0198	0.0207	CcSEcCtD
Saxagliptin—Anaphylactic shock—Riluzole—amyotrophic lateral sclerosis	0.0191	0.02	CcSEcCtD
Saxagliptin—Infection—Riluzole—amyotrophic lateral sclerosis	0.019	0.0199	CcSEcCtD
Saxagliptin—Thrombocytopenia—Riluzole—amyotrophic lateral sclerosis	0.0187	0.0196	CcSEcCtD
Saxagliptin—Skin disorder—Riluzole—amyotrophic lateral sclerosis	0.0185	0.0194	CcSEcCtD
Saxagliptin—Musculoskeletal discomfort—Riluzole—amyotrophic lateral sclerosis	0.0174	0.0182	CcSEcCtD
Saxagliptin—Dyspepsia—Riluzole—amyotrophic lateral sclerosis	0.0168	0.0176	CcSEcCtD
Saxagliptin—Gastrointestinal disorder—Riluzole—amyotrophic lateral sclerosis	0.0165	0.0173	CcSEcCtD
Saxagliptin—Fatigue—Riluzole—amyotrophic lateral sclerosis	0.0165	0.0172	CcSEcCtD
Saxagliptin—Gastrointestinal pain—Riluzole—amyotrophic lateral sclerosis	0.0156	0.0163	CcSEcCtD
Saxagliptin—Urticaria—Riluzole—amyotrophic lateral sclerosis	0.0152	0.0159	CcSEcCtD
Saxagliptin—Abdominal pain—Riluzole—amyotrophic lateral sclerosis	0.0151	0.0158	CcSEcCtD
Saxagliptin—Hypersensitivity—Riluzole—amyotrophic lateral sclerosis	0.0141	0.0147	CcSEcCtD
Saxagliptin—Asthenia—Riluzole—amyotrophic lateral sclerosis	0.0137	0.0143	CcSEcCtD
Saxagliptin—Pruritus—Riluzole—amyotrophic lateral sclerosis	0.0135	0.0141	CcSEcCtD
Saxagliptin—Dizziness—Riluzole—amyotrophic lateral sclerosis	0.0126	0.0132	CcSEcCtD
Saxagliptin—Vomiting—Riluzole—amyotrophic lateral sclerosis	0.0121	0.0127	CcSEcCtD
Saxagliptin—Rash—Riluzole—amyotrophic lateral sclerosis	0.012	0.0126	CcSEcCtD
Saxagliptin—Dermatitis—Riluzole—amyotrophic lateral sclerosis	0.012	0.0126	CcSEcCtD
Saxagliptin—Headache—Riluzole—amyotrophic lateral sclerosis	0.012	0.0125	CcSEcCtD
Saxagliptin—Nausea—Riluzole—amyotrophic lateral sclerosis	0.0113	0.0119	CcSEcCtD
Saxagliptin—DPP8—medulla oblongata—amyotrophic lateral sclerosis	0.00632	0.139	CbGeAlD
Saxagliptin—DPP8—spinal cord—amyotrophic lateral sclerosis	0.00564	0.124	CbGeAlD
Saxagliptin—DPP9—cerebellum—amyotrophic lateral sclerosis	0.00491	0.108	CbGeAlD
Saxagliptin—DPP8—cerebellum—amyotrophic lateral sclerosis	0.00447	0.0986	CbGeAlD
Saxagliptin—DPP4—embryo—amyotrophic lateral sclerosis	0.00415	0.0917	CbGeAlD
Saxagliptin—DPP9—brain—amyotrophic lateral sclerosis	0.00399	0.088	CbGeAlD
Saxagliptin—DPP8—brain—amyotrophic lateral sclerosis	0.00363	0.0801	CbGeAlD
Saxagliptin—DPP4—nervous system—amyotrophic lateral sclerosis	0.00199	0.044	CbGeAlD
Saxagliptin—DPP4—central nervous system—amyotrophic lateral sclerosis	0.00192	0.0424	CbGeAlD
Saxagliptin—DPP4—brain—amyotrophic lateral sclerosis	0.00152	0.0336	CbGeAlD
Saxagliptin—SLC22A8—nervous system—amyotrophic lateral sclerosis	0.00131	0.029	CbGeAlD
Saxagliptin—SLC22A8—central nervous system—amyotrophic lateral sclerosis	0.00126	0.0279	CbGeAlD
Saxagliptin—ABCC1—cerebellum—amyotrophic lateral sclerosis	0.00106	0.0234	CbGeAlD
Saxagliptin—SLC22A8—brain—amyotrophic lateral sclerosis	0.001	0.0221	CbGeAlD
Saxagliptin—ABCC1—brain—amyotrophic lateral sclerosis	0.000862	0.019	CbGeAlD
Saxagliptin—CYP3A4—nervous system—amyotrophic lateral sclerosis	0.00065	0.0144	CbGeAlD
Saxagliptin—CYP3A4—central nervous system—amyotrophic lateral sclerosis	0.000626	0.0138	CbGeAlD
